MariMed Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

NOTE 6 - STOCK OPTIONS

NOTE 6 - STOCK OPTIONS

3 Months Ended

Mar. 31, 2016

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

NOTE 6 – STOCK OPTIONS

During the three months ended March 31, 2016, the Company issued 40,000 warrants and recorded a warrant expense of $5,154 equal to the estimated fair value of the warrants at the date of grants. The fair market value was calculated using the Black-Scholes options pricing model, assuming approximately 1.24% risk-free interest, 0% dividend yield, 298% volatility, and expected life of 3 years. There were no stock options issued during the three months ended March 31, 2016.

During the three months ended March 31, 2015, no stock options or warrants were exercised.

Stock options outstanding and exercisable as of March 31, 2016 are as follows:
Exercise Price per Share		Shares Under Option		Remaining Life in Years
	Outstanding
$	0.08		450,000		2.75
$	0.025		200,000		1.75
$	0.025		500,000		1.72
$	0.01		4,500,000		1.42
$	0.13		600,000		4.25
$	0.15		1,000,000		3.14
$	0.25		1,000,000		3.14
$	0.35		1,000,000		3.14
			9,250,000
	Exercisable
$	0.08		450,000		2.75
$	0.025		200,000		1.75
$	0.025		500,000		1.72
$	0.01		4,500,000		1.42
$	0.15		1,000,000		3.14
			6,650,000